HK26596A - Clavam derivatives preparation and intermediates therefor - Google Patents

Clavam derivatives preparation and intermediates therefor

Info

Publication number
HK26596A
HK26596A HK26596A HK26596A HK26596A HK 26596 A HK26596 A HK 26596A HK 26596 A HK26596 A HK 26596A HK 26596 A HK26596 A HK 26596A HK 26596 A HK26596 A HK 26596A
Authority
HK
Hong Kong
Prior art keywords
intermediates therefor
derivatives preparation
clavam
clavam derivatives
preparation
Prior art date
Application number
HK26596A
Other languages
English (en)
Inventor
Stephen William Elson
Stefan Roland Woroniecki
Keith Howard Baggaley
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of HK26596A publication Critical patent/HK26596A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/10Optical coatings produced by application to, or surface treatment of, optical elements
    • G02B1/14Protective coatings, e.g. hard coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
HK26596A 1985-08-29 1996-02-08 Clavam derivatives preparation and intermediates therefor HK26596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858521516A GB8521516D0 (en) 1985-08-29 1985-08-29 Compounds

Publications (1)

Publication Number Publication Date
HK26596A true HK26596A (en) 1996-02-16

Family

ID=10584437

Family Applications (1)

Application Number Title Priority Date Filing Date
HK26596A HK26596A (en) 1985-08-29 1996-02-08 Clavam derivatives preparation and intermediates therefor

Country Status (11)

Country Link
US (2) US4795809A (de)
EP (1) EP0213914B1 (de)
JP (4) JP2530825B2 (de)
AT (1) ATE82291T1 (de)
CA (1) CA1338143C (de)
DE (1) DE3687100T2 (de)
ES (1) ES2001410A6 (de)
GB (1) GB8521516D0 (de)
GR (1) GR862214B (de)
HK (1) HK26596A (de)
PT (1) PT83267B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813055D0 (en) * 1988-06-02 1988-07-06 Beecham Group Plc Novel substance
JP3730263B2 (ja) * 1992-05-27 2005-12-21 ケーエルエー・インストルメンツ・コーポレーション 荷電粒子ビームを用いた自動基板検査の装置及び方法
JP3558295B2 (ja) * 1992-12-02 2004-08-25 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー クラブラン酸の製法
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
GB9702218D0 (en) * 1997-02-04 1997-03-26 Smithkline Beecham Plc Novel product

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862008A (en) * 1973-12-03 1975-01-21 Lilly Co Eli Process for deacetoxycephalosporin c.
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
GB1563103A (en) * 1975-10-13 1980-03-19 Beecham Group Ltd Process for the preparation of clavulanic acid
US4078067A (en) * 1976-04-12 1978-03-07 Merck & Co., Inc. 3-(.beta.-Aminoethylidene)-7-oxo-4-oxaazabicyclo[3.2.0]heptane-2-carboxylic acid and derivatives thereof
GB1585124A (en) * 1976-06-04 1981-02-25 Glaxo Lab Ltd Clavulanic acid derivatives
FI773157A (fi) * 1976-10-25 1978-04-26 Glaxo Lab Ltd Kemiska foereningar
GB1603208A (en) * 1977-04-27 1981-11-18 Beecham Group Ltd Aminodeoxyclavulanic acid and acyl derivatives threreof
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
JPS5835677B2 (ja) * 1982-08-05 1983-08-04 武田薬品工業株式会社 新菌種ストレプトミセス・カツラハマヌス

Also Published As

Publication number Publication date
JP2698062B2 (ja) 1998-01-19
GB8521516D0 (en) 1985-10-02
JPH08266274A (ja) 1996-10-15
JPH08259530A (ja) 1996-10-08
CA1338143C (en) 1996-03-12
ATE82291T1 (de) 1992-11-15
JPH08242874A (ja) 1996-09-24
DE3687100T2 (de) 1993-04-15
US4795809A (en) 1989-01-03
EP0213914B1 (de) 1992-11-11
GR862214B (en) 1986-12-31
JP2648472B2 (ja) 1997-08-27
JP2604571B2 (ja) 1997-04-30
EP0213914A2 (de) 1987-03-11
PT83267B (pt) 1988-08-17
JP2530825B2 (ja) 1996-09-04
EP0213914A3 (en) 1988-07-27
US5130241A (en) 1992-07-14
ES2001410A6 (es) 1988-05-16
JPS6259281A (ja) 1987-03-14
DE3687100D1 (de) 1992-12-17
PT83267A (en) 1986-09-01

Similar Documents

Publication Publication Date Title
ES2005745A6 (es) Un procedimiento para preparar arilpiperindionas.
ES8704161A1 (es) Un procedimiento para preparar dihidroquinoleinas antibacterianas.
ES8801920A1 (es) Procedimiento para la obtencio de enaminas
NO860424L (no) Fremgangsmaate ved fremstilling av 6-thioxanthinderivater.
AU8293387A (en) Quinoline compound
EP0213914A3 (en) Clavam derivatives, preparation and intermediates therefor
HUT40614A (en) Process for production of derivatives of amin-akryl-acid
AU580668B2 (en) A new process for the optical resolution of racemic mixtures of ``-naphthylpropionic acids
IL67473A (en) Preparation of bicycloheptane derivatives and certain such novel compounds
ES8703470A1 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
ES2000405A6 (es) Procedimiento para la preparacion de cotarnina
AU575964B2 (en) Pineapple ketone carbonate derivatives
ES8609219A1 (es) Un procedimiento para producir un derivado de difenilmetilimina
ES8700859A1 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES8307251A1 (es) Un procedimiento para la preparacion de derivados de acido clavulanico.
ES8704447A1 (es) Un procedimiento para preparar el homero s de un 3-eter de 2-hidroxi -profil-amina.
ES8606271A1 (es) Procedimiento de preparacion de sulfonamidas con agrupacion imido
ES8801641A1 (es) Un procedimiento para la preparacion de derivados de beurazepina.
DE2966347D1 (en) Clavulanic acid derivatives and process for their preparation
ES8609316A1 (es) Un procedimiento para la produccion de nuevos derivados de ergolina
ES2194871T3 (es) Deshidrogenasa del acido clavulanico, preparacion y uso para la produccion de acido clavulanico.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)